Quarterly report pursuant to Section 13 or 15(d)

Condensed Statements of Operations (Unaudited)

v3.20.2
Condensed Statements of Operations (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Jun. 30, 2020
Jun. 30, 2019
Income Statement [Abstract]        
Revenues
Operating expenses:        
Research and development 1,545,043 1,418,426 2,994,915 2,790,274
General and administrative 1,390,671 1,539,305 3,222,292 2,995,502
Total operating expenses 2,935,714 2,957,731 6,217,207 5,785,776
Operating loss (2,935,714) (2,957,731) (6,217,207) (5,785,776)
Other income (expense):        
Interest income 1,743 87,488 37,192 181,893
Interest expense (77,837) (77,837) (155,673) (154,818)
Equity modification expense (998,643)   (1,801,043)
Amortization of debt discount and offering costs (92,078) (109,962) (183,361) (219,925)
Total other expense (1,166,815) (100,311) (2,102,885) (192,850)
Net loss $ (4,102,529) $ (3,058,042) $ (8,320,092) $ (5,978,626)
Basic and diluted net loss per share $ (0.09) $ (0.07) $ (0.19) $ (0.14)
Weighted average common shares outstanding - basic and diluted 43,336,953 42,799,486 43,228,161 42,717,950